HRCT Features of Small Peripheral Lung Carcinomas Detected in a Low-dose CT Screening Program
Rationale and Objectives
To define high-resolution computed tomography (HRCT) features of lung cancers detected by computed tomography (CT) screening according to histopathology and prognosis.
Methods and Materials
Tumor size, CT value, morphology, and tumor volume doubling time (TVDT) were determined for 10 atypical adenomatous hyperplasias (AAH) and 50 lung cancers followed between 1996 and 1998 to 2007.
Results
For the 10 AAHs, the density less than −500 HU in all lesions (mean, −654 HU) and the size was up to 14 mm (mean, 9 mm); all patients remain alive. Focal bronchioloalveolar cell carcinomas (BAC) were denser (mean, −537 HU) than AAH and mostly less dense than −350 HU; all patients remain alive. All 22 adenocarcinomas (ADC) were denser than −450 HU (mean, −186 HU); 6 were problematic and measured >−150HU and >10 mm or had >10 mm of central denser zone (CDZ) (partly solid tumors) or tumor size (solid tumor). Two of four squamous cell carcinomas (SCC) measuring 15 and 10 mm, respectively, were problematic. Two patients with small-cell lung carcinomas (SCLC) measuring 15 and 23 mm, respectively, remain alive. AAH, BAC, ADC, and SCC lesions were in general polygonal in shape. SCLC lesions appeared as round nodules with excrescence. The mean TVDT for AAH, BAC, ADC, SCC, and SCLC was 1278, 557, 466, 212, and 103 days, respectively.
Conclusion
The CT features reflected tumor aggressiveness. Non-SCLC lesions of >−150HU and >10 mm (or >−100HU and >10 mm for the solid portion of the tumor) are associated with unfavorable prognosis. Timely interventions should be undertaken before problematic increase in number of cases.
Key Words: Lung cancer, screening, computed tomography (CT), lung periphery, chest
To access this article, please choose from the options below
Follow-up studies of the subjects in the computed tomography screening program was supported in part by a Gant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan (Third Term Comprehensive Control Research for Cancer; No 16271201).
PII: S1076-6332(09)00447-4
doi:10.1016/j.acra.2009.08.003
© 2010 AUR. Published by Elsevier Inc. All rights reserved.
